Latest filing published 03 Nov 2026 for HERON THERAPEUTICS, INC. /DE/.
Insider track record
No signal scores available.
Mark Earl Hensley: trading record in brief
Mark Earl Hensley is a declared insider of Heron Therapeutics, Inc. /DE/, with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 31 July 2026 and the latest from 30 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 November 2026, the filings show an option exercise in Heron Therapeutics, Inc. /DE/. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Earl Hensley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,770 sharesCommon StockSEC:0001193125-26-444831:0
- 3,349 shares@ US$0.28Common StockSEC:0001193125-26-444831:1
- 31,250 sharesCommon StockSEC:0001193125-26-341528:0
- 8,888 shares@ US$0.500.0079% mcap100.0% of flowCommon StockSEC:0001193125-26-341528:1
- 11,769 sharesCommon StockSEC:0001193125-26-329848:0
5 of 5 declarations
